secwatch.observer — SEC 8-K summary
======================================

Issuer:     CervoMed Inc. (CRVO)
CIK:        0001053691
Form:       8-K
Filed at:   2026-10-09T20:06:30+00:00
Accession:  0001437749-26-032445
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

CervoMed posts investor presentation covering business, clinical studies, development plans, and financial position
--------------------------------------------------------------------------------

- CervoMed Inc. (CRVO) made a presentation available on www.cervomed.com under 'Investors – Events and Presentations' on October 9, 2026.
- Presentation covers the company's business, clinical studies, development plans, financial position, and related matters; may be used in investor and analyst meetings.
- The filing was signed by William Elder, Chief Financial Officer & General Counsel, on October 9, 2026.
- CervoMed common stock, $0.001 par value, trades on the NASDAQ Capital Market under symbol CRVO.
- The company states it has no duty to update the presentation except as required by law and makes no admission as to its materiality.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053691/000143774926032445/0001437749-26-032445-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053691/000143774926032445/crvo20261009_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-032445

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer